| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 08/14/2002 | EP1230929A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230263A1 A novel molecule |
| 08/14/2002 | EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1229965A2 Placental human neurokinin b precursor |
| 08/14/2002 | EP1229906A2 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders |
| 08/14/2002 | EP1087961B1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 08/14/2002 | EP1071455A4 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/14/2002 | CN1364093A Improvement of T cell mediated immunity |
| 08/14/2002 | CN1364080A Th2 differentiation inhibitors |
| 08/14/2002 | CN1363385A Chinese-medicine prescription and process for preparing medicine wine |
| 08/14/2002 | CN1363384A Prescription and process for preparing medical wine |
| 08/14/2002 | CN1363381A Composition for increasing egg-laying rate of hen |
| 08/14/2002 | CN1363347A Nano medicine 'Nubao' and its preparing process |
| 08/14/2002 | CN1363336A Nano encommia bark medicine and its preparing process |
| 08/14/2002 | CN1363279A Compound roxithromycin suppository |
| 08/14/2002 | CN1089003C Yang Strengthening importance-eliminating decoction |
| 08/14/2002 | CN1088993C Long-acting subcutaneous contraceptive implanting agent containing pregnadienone |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/13/2002 | US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433149 Compounds and methods for inhibiting cancer metastasis |
| 08/13/2002 | US6433135 Polyoxyethylene glycol luteinizing hormone releasing hormone bound for serine |
| 08/13/2002 | US6433022 Exposure of semen to naphthoquinone/1,4-/ or juglone; reduction to semiquinone and generation of oxygen, superoxide, hydrogen peroxide, or free radicals; immobilization |
| 08/13/2002 | US6433005 Selective cox ii inhibitor |
| 08/13/2002 | US6432996 Pharmaceutical composition |
| 08/13/2002 | US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents |
| 08/13/2002 | US6432983 Treating estrogen-dependent cancer, endometriosis, osteoporosis, post-menopausal disorders and hyperlipidemia; restenosis inhibitors |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432943 Method for treating sexual dysfunction |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
| 08/08/2002 | WO2002060903A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | WO2002060459A2 Use of iodide salt as an aphrodisiac |
| 08/08/2002 | WO2002060458A2 Compositions and method of tissue superoxygenation |
| 08/08/2002 | WO2002060449A2 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | WO2002060428A2 Methods of using and compositions comprising (-)sibutramine optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060427A2 Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060424A2 Methods of using and compositions comprising sibutramine metabolites optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060423A2 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 08/08/2002 | WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | WO2002044142A3 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002019971A9 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/08/2002 | WO2002014347A3 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 08/08/2002 | WO2002011735A3 Association of a purine activity and a nonsteroidal anti-inflammatory anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002011665A3 Association of a purine and a nonsteroidal anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002009690A3 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 08/08/2002 | WO2002003993A3 Use of inhibitors to multidrug resistance protein 5 (mrp5) to enhance intracellular levels of cyclic nucleotides |
| 08/08/2002 | WO2002003986A3 Use of substituted indole compounds for treating breast disorders |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 08/08/2002 | WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 08/08/2002 | WO2001070211A3 L-arginine and phosphodiesterase (pde) inhibitor synergism |
| 08/08/2002 | WO2001032925A9 Modulation of neuroendocrine differentiation by protein 25.1 |
| 08/08/2002 | WO2001016330A3 Prevention of affections associated with porcine circovirus-2 |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107280 Selective COX II inhibitor |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107262 Substituted imidazopyridines |
| 08/08/2002 | US20020107254 P-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-N-pyridin-2-yl-benzamide, |
| 08/08/2002 | US20020107247 Method of treating sexual disturbances |
| 08/08/2002 | US20020107236 Methods of treating sexual dysfunction associated with hypertension |
| 08/08/2002 | US20020107230 Methods and formulations for the treatment of female sexual dysfunction |
| 08/08/2002 | US20020107229 Multistage preparation for contraception: 2-4 first stage daily dosage including a natural estrogen, form 16-22 second stage daily dosage portions including a natural or synthetic gestogen and a natural estrogen, and a specific third dosage |
| 08/08/2002 | US20020107197 Ligands for G protein coupled receptors and methods of using them |
| 08/08/2002 | US20020107182 Compositions and methods for treatment of sexual dysfunction |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | CA2436427A1 Compositions and method of tissue superoxygenation |
| 08/08/2002 | CA2436209A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | CA2429969A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228064A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters |
| 08/07/2002 | EP1228055A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents |
| 08/07/2002 | EP1228047A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228041A2 Indole derivatives and their use as 5ht2a ligands |
| 08/07/2002 | EP1227820A2 Oligosaccharide aldonic acids and their topical use |
| 08/07/2002 | EP1227815A1 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same |
| 08/07/2002 | EP1227814A1 Hormonal composition based on a progesterone and an oestrogen and use thereof |
| 08/07/2002 | EP1227805A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |